Otsuka MDR-Tuberculosis R&D
Since 2004 Otuska has invested over a half a billion US dollars in TB research and development leading to the...
Otsuka
Back to List
Otsuka
COLLABORATIONS
SHOWING 3 of 3 COLLABORATIONS
See All
Otsuka FighTBack Initiative
This is an initiative to scale-up access to delamanid in all low, middle-income and high-burden MDR-TB...
Otsuka
Global Health Innovative Technology (GHIT) Fund
Japanese-led initiative aiming to discover and advance the development of new health technologies such as...
Eisai, Astellas Pharma Inc, Chugai Pharmaceutical, Daiichi Sankyo, JPMA, Otsuka, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited
SHOWING 3 of 3 COLLABORATIONS
See All